Lasting success, however, comes from pairing that tool with healthy, sustainable habits
The rationale is that long term adherence remains one of the biggest challenges for GLP 1 medicines, with some studies estimating that roughly half of patients discontinue treatment within a year because of side effects, cost, injection fatigue, or stigma
J Biol Chem 280:1231612329 Chen YQ, Min C, Sang M, Han YY, Ma X, Xue XQ, Zhang SQ (2010) A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells
Pharmacokinetic parameters that may not have been elucidated in humans should also be considered as the reason for these differences
Kuan J, Brock G